Enzon Announces Consolidation of Its Manufacturing Operations in Indianapolis

06-Feb-2007

Enzon Pharmaceuticals, Inc. announced plans to consolidate its manufacturing operations in Indianapolis from its South Plainfield, N.J. facility, resulting in the discontinuation of all activity at that location. The closing of this manufacturing facility is expected to impact approximately fifty employees, and the Company will assist them in their transition.

This announcement comes as part of Enzon's continued efforts to streamline operations to optimize efficiencies and position the Company for long-term, sustainable growth. Enzon continues to focus investment on key priorities for the business including developing innovative oncology therapies and advancing its clinical pipeline.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance